TB-CAPT session at ASLM LabCop 2022 Annual Meeting
On 12 October 2022, TB-CAPT the TB-CAPT consortium organised a session on scaling solutions for near point-of-care and point-of-care molecular testing services for tuberculosis (TB) and drug-resistant TB. The session was organised in collaboration with USAID and the Stop TB Partnership. TB-CAPT (Close the gap, increase Access, Provide adequate Therapy) will provide evidence for impactful implementation of tuberculosis (TB) and TB/HIV co-infection diagnostic strategies including drug-susceptibility testing through a series of trials in Tanzania, Mozambique, and South Africa. The session recording is available on the TB-CAPT website.